Eradication versus control for poliomyelitis

Anita Kar¹

Affiliations

Comment

Anita Kar. Lancet. 2007.

. 2007 Jul 14;370(9582):131-132.

doi: 10.1016/S0140-6736(07)61080-0.

Anita Kar¹

¹ Interdisciplinary School of Health Sciences, University of Pune, Pune 411007, India. Electronic address: akar@unipune.ernet.in.

No abstract available

Comment on

Protective efficacy of a monovalent oral type 1 poliovirus vaccine: a case-control study.
Grassly NC, Wenger J, Durrani S, Bahl S, Deshpande JM, Sutter RW, Heymann DL, Aylward RB. Grassly NC, et al. Lancet. 2007 Apr 21;369(9570):1356-1362. doi: 10.1016/S0140-6736(07)60531-5. Lancet. 2007. PMID: 17448821
Eradication versus control for poliomyelitis: an economic analysis.
Thompson KM, Tebbens RJD. Thompson KM, et al. Lancet. 2007 Apr 21;369(9570):1363-1371. doi: 10.1016/S0140-6736(07)60532-7. Lancet. 2007. PMID: 17448822 Review.